Amicus Therapeutics
Amicus Therapeutics's Overview
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. With a strong pipeline and a commitment to the rare disease community, Amicus strives to provide innovative treatments that can make a meaningful difference in patients' lives. Their primary focus areas include lysosomal storage disorders, with approved therapies for Fabry disease (Galafold®) and Pompe disease (Pombiliti™ + Opfolda™).
Where is Amicus Therapeutics's Headquarters?
HQ Function
Global corporate headquarters, overseeing strategic direction, research and development leadership, commercial operations, finance, legal, and administrative functions for Amicus's worldwide activities.
Notable Features:
Located within uCity Square, a dynamic life sciences and technology hub in Philadelphia, offering modern facilities designed to foster collaboration and innovation. Proximity to leading academic and research institutions.
Work Culture:
Patient-focused and science-driven, emphasizing collaboration, innovation, and a strong sense of community. Employees are often mission-oriented, dedicated to making a difference in the lives of individuals with rare diseases.
HQ Significance:
Represents Amicus's commitment to growth and innovation in the U.S. life sciences corridor. Centralizes key global functions and serves as the main hub for its research into lysosomal storage disorders and development of novel therapies.
Values Reflected in HQ: The choice of a modern, collaborative space in a leading innovation district reflects Amicus's values of scientific excellence, innovation, and a forward-looking approach to tackling rare diseases.
Location:
Amicus Therapeutics maintains a global footprint to support its mission, with operations spanning North America, Europe, and the Asia-Pacific region. Core functions managed internationally include clinical research and development across multiple countries, commercialization and market access for its approved therapies (such as Galafold® and Pombiliti™ + Opfolda™), medical affairs, regulatory interactions with global health authorities, manufacturing and supply chain logistics, and robust patient advocacy and support programs tailored to regional needs.
Street Address:
3675 Market Street
City:
Philadelphia
State/Province:
PA
Country:
USA
Amicus Therapeutics's Global Presence
Weybridge, Surrey, United Kingdom
Address: 1st Floor, Building 5, The Heights Business Park, Weybridge, Surrey, KT13 0NY, United Kingdom
Facilitates the delivery of approved therapies to patients in the EMEA region, manages clinical trial activities, and engages with regional healthcare stakeholders.
Tokyo, Japan
Address: PMO Nishi-Shinbashi 3F, 3-17-7 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
To serve patients with rare diseases in Japan, ensuring access to therapies and engaging with the local medical community, patient organizations, and regulatory authorities.
Buying Intent Signals for Amicus Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Amicus Therapeutics
As of April 2025, Amicus Therapeutics' leadership includes:
Investors of Amicus Therapeutics
Amicus Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Amicus Therapeutics strengthened its leadership with the appointment of a new Chief Medical Officer in August 2023. The executive team has otherwise shown stability at the C-suite level based on public announcements in the past year.
New Appointments:
Technology (Tech Stack) used by Amicus Therapeutics
Discover the tools Amicus Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Amicus Therapeutics Email Formats and Examples
Amicus Therapeutics commonly uses the email format of first initial followed by the last name. While other formats might exist, this is a prevalent structure for corporate communications.
[firstinitial][lastname]@amicusrx.com
Format
jdoe@amicusrx.com
Example
80%
Success rate
News and media
GlobeNewswire • February 28, 2024
Amicus Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Amicus Therapeutics reported its financial performance for the fourth quarter and full year 2023, highlighting continued strong Galafold® revenue growth and successful global launch of Pombiliti™ and Opfolda™ for Pompe disease. The company provided updates on its strategic priorities for 2024, focusing on maximizing commercial products and advancing its pipeline....more
Amicus Therapeutics Investor Relations • January 8, 2024
Amicus Therapeutics Presents at the 42nd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics presented its strategic outlook, commercial achievements, and research and development pipeline progress at the 42nd Annual J.P. Morgan Healthcare Conference. The presentation emphasized the company's dedication to patients with rare diseases and its key drivers for long-term growth and value creation....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Amicus Therapeutics, are just a search away.